Cargando…
Comment on: Atkinson. It's Time to Consider Changing the Rules: The Rationale for Rethinking Control Groups in Clinical Trials Aimed at Reversing Type 1 Diabetes. Diabetes 2011;60:361–363
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3114381/ https://www.ncbi.nlm.nih.gov/pubmed/21617183 http://dx.doi.org/10.2337/db11-0253 |
_version_ | 1782206057700917248 |
---|---|
author | Sanda, Srinath Greenbaum, Carla J. |
author_facet | Sanda, Srinath Greenbaum, Carla J. |
author_sort | Sanda, Srinath |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-3114381 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | American Diabetes Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-31143812012-06-01 Comment on: Atkinson. It's Time to Consider Changing the Rules: The Rationale for Rethinking Control Groups in Clinical Trials Aimed at Reversing Type 1 Diabetes. Diabetes 2011;60:361–363 Sanda, Srinath Greenbaum, Carla J. Diabetes Online Letters to the Editor American Diabetes Association 2011-06 2011-05-21 /pmc/articles/PMC3114381/ /pubmed/21617183 http://dx.doi.org/10.2337/db11-0253 Text en © 2011 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details. |
spellingShingle | Online Letters to the Editor Sanda, Srinath Greenbaum, Carla J. Comment on: Atkinson. It's Time to Consider Changing the Rules: The Rationale for Rethinking Control Groups in Clinical Trials Aimed at Reversing Type 1 Diabetes. Diabetes 2011;60:361–363 |
title | Comment on: Atkinson. It's Time to Consider Changing the Rules: The Rationale for Rethinking Control Groups in Clinical Trials Aimed at Reversing Type 1 Diabetes. Diabetes 2011;60:361–363 |
title_full | Comment on: Atkinson. It's Time to Consider Changing the Rules: The Rationale for Rethinking Control Groups in Clinical Trials Aimed at Reversing Type 1 Diabetes. Diabetes 2011;60:361–363 |
title_fullStr | Comment on: Atkinson. It's Time to Consider Changing the Rules: The Rationale for Rethinking Control Groups in Clinical Trials Aimed at Reversing Type 1 Diabetes. Diabetes 2011;60:361–363 |
title_full_unstemmed | Comment on: Atkinson. It's Time to Consider Changing the Rules: The Rationale for Rethinking Control Groups in Clinical Trials Aimed at Reversing Type 1 Diabetes. Diabetes 2011;60:361–363 |
title_short | Comment on: Atkinson. It's Time to Consider Changing the Rules: The Rationale for Rethinking Control Groups in Clinical Trials Aimed at Reversing Type 1 Diabetes. Diabetes 2011;60:361–363 |
title_sort | comment on: atkinson. it's time to consider changing the rules: the rationale for rethinking control groups in clinical trials aimed at reversing type 1 diabetes. diabetes 2011;60:361–363 |
topic | Online Letters to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3114381/ https://www.ncbi.nlm.nih.gov/pubmed/21617183 http://dx.doi.org/10.2337/db11-0253 |
work_keys_str_mv | AT sandasrinath commentonatkinsonitstimetoconsiderchangingtherulestherationaleforrethinkingcontrolgroupsinclinicaltrialsaimedatreversingtype1diabetesdiabetes201160361363 AT greenbaumcarlaj commentonatkinsonitstimetoconsiderchangingtherulestherationaleforrethinkingcontrolgroupsinclinicaltrialsaimedatreversingtype1diabetesdiabetes201160361363 |